BioNTech to Present Multiple Program Updates Across
Program updates include new data for investigational CAR-T and ex-vivo T cell therapies, a novel ADC, a FixVac off-the-shelf mRNA cancer vaccine, and a...
Source: globenewswire.com
Page 10 - Biontech Se News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Biontech Se. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Biontech Se Today - Breaking & Trending Today
Stocks making the biggest moves premarket: PFE, LULU, SCHW and more
These are the stocks posting the largest moves in premarket trading.
Source: cnbc.com
Downturn in US demand leads to course correction for COVID-19 vaccines, therapy
The vagaries of the COVID-19 market and the uncertainties of pandemic fatigue are hitting some biopharma companies in the pocketbook, at least for now. Due to lower-than-expected revenues from its COVID-19 Comirnaty vaccine and antiviral Paxlovid (nirmatrelvir/ritonavir), Pfizer Inc. reduced its 2023 revenue guidance by $9 billion after hours Oct. 13, saying it now anticipates full-year 2023 revenues to range from $58 billion to $61 billion – down from its previous guidance range of $67 billion to $70 billion.
Source: bioworld.com
Pfizer Stock Drops After Guidance Cut. Its Post-Covid Place Is Unsure.
The U.S. government will return treatments of the company's Paxlovid drug as coronavirus vaccination rates fall.
Source: marketwatch.com
Stocks making the biggest moves midday: LULU, PFE, NWSA, SCHW and more
These are the stocks posting the largest moves midday.
Source: cnbc.com